. . . . . . . . . . . . . . . . . "a(SCHEM:\"Ro 31-8425\") -| (a(SCHEM:Dinoprostone) -> p(HGNC:MAPK3,pmod(P,T,202)))" . "a(SCHEM:Dinoprostone) -> p(HGNC:MAPK3,pmod(P,T,202))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "NSCLC cells were pretreated with the selective and potent (IC50 = 15 nmol/L) PKC inhibitor Ro-31-8425 prior to PGE2 stimulation. We found that inhibition of PKC significantly blocks PGE2-dependent Erk phosphorylation in NSCLC cells (Fig. 5A). " . . "Selventa" . . . . "2014-07-03T14:32:47.634+02:00"^^ . . .